title: Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia.
authors.affiliation: Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, The Netherlands.
authors.forename: Arend Jan Gerard
authors.initials: AJ
authors.lastname: Jansen
authors.forename: Jun
authors.initials: J
authors.lastname: Peng
authors.forename: Hong-Guo
authors.initials: HG
authors.lastname: Zhao
authors.forename: Ming
authors.initials: M
authors.lastname: Hou
authors.forename: Heyu
authors.initials: H
authors.lastname: Ni
mesh_terms: D001792:Blood Platelets / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology / Q000821:virology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology / Q000821:virology; D008297:Male; D008875:Middle Aged; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D053139:Oseltamivir / Q000627:therapeutic use*; D010976:Platelet Count; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology / Q000821:virology; D016896:Treatment Outcome
chemical_list: D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D019158:N-Acetylneuraminic Acid